Event name: 5th Congress of the European Academy of Neurology (EAN)
The overarching theme is “Neuroinflammation– Science, Synergies, Solutions”. The role of neuroinflammatory process is currently a hot topic in both understanding neurological diseases and in developing new therapies for nervous system diseases. Different aspects of neuroinflammation but also other diseases will be highlighted during the congress across a broad spectrum of sessions.
Date: June 29 – July 2 2019
Venue: Oslo, Norway
Information page: www.ean.org/oslo2019
Please come and chat to ERN-RND and EURO-NMD members at booth C61.
Chloe Blewitt from EURO-NMD will be answering questions about the Clinicial Patient Management System (CPMS).
Don’t miss the following session presented by ERN-RND members:
Session title: “The lesson from Rare Neurological Diseases for understanding nervous system functions and dysfunctions”
Date: June 29, 16:45
Holm Graessner, Tübingen, Germany
The neurologist’s viewpoint
Antonio Federico, Siena, Italy
The geneticist’s viewpoint
Tobias Haack, Tuebingen, Germany
The child neurologist’s viewpoint
Nicole Wolf, Amsterdam, The Netherlands
Perspectives of therapies
Maria J. Molnar, Budapest, Hungary
Summary: the workshop will consider rare neurologic diseases as a model to discuss how an identified molecular or biochemical alteration will reflect on the dysfunction of the nerve system and in consequence identify a specific role in normal CNS function. The interaction between clinical neurologists, geneticists and neuro-pediatricians will also give the opportunity to discuss about the clinical and genetic heterogeneity, the higher vulnerability of several CNS area to a dysmetabolic changes, the possibility of symptoms in carriers, and the new findings suggested by the used of new genetic technologies, enlarging the phenotypic presentation.
Please find the Scientific Programme of the EAN Congress here.